David R Murdoch
Overview
Explore the profile of David R Murdoch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
208
Citations
7323
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jolliffe D, Camargo Jr C, Sluyter J, Aglipay M, Aloia J, Bergman P, et al.
Lancet Diabetes Endocrinol
. 2025 Feb;
PMID: 39993397
Background: A 2021 meta-analysis of 37 randomised controlled trials (RCTs) of vitamin D supplementation for prevention of acute respiratory infections (ARIs) revealed a statistically significant protective effect of the intervention...
2.
Straub C, Taylor W, French N, Murdoch D, Priest P, Anderson T, et al.
Microb Genom
. 2024 Dec;
10(12).
PMID: 39630492
Zoonotic pathogen transmission is of growing concern globally, with agricultural intensification facilitating interactions between humans, livestock and wild animals. is a major human pathogen, but it also causes mastitis in...
3.
Miyakawa R, Zhang H, Brooks W, Prosperi C, Baggett H, Feikin D, et al.
Clin Microbiol Infect
. 2024 Nov;
31(3):441-450.
PMID: 39489292
Objectives: After respiratory syncytial virus (RSV), human metapneumovirus (hMPV) was the second-ranked pathogen attributed to severe pneumonia in the PERCH study. We sought to characterize hMPV-positive cases in high-burden settings,...
4.
5.
Maze M, Williman J, Anstey R, Best E, Bhally H, Bryce A, et al.
IJID Reg
. 2024 Sep;
12:100424.
PMID: 39281192
Objectives: COVID-19 severity prediction scores need further validation due to evolving COVID-19 illness. We evaluated existing COVID-19 risk prediction scores in Aotearoa New Zealand, including for Māori and Pacific peoples...
6.
Jun H, Chambers S, Williman J, Slow S, Murdoch D, Scott-Thomas A
Lett Appl Microbiol
. 2024 Aug;
77(9).
PMID: 39215554
Legionella longbeachae is the leading cause of Legionnaires' disease (LD) in Australasia and has been linked to exposure to compost and potting soils. Adding antimicrobial metal ions such as copper...
7.
Taylor A, Best E, Walls T, Webb R, Bhally H, Bryce A, et al.
IJID Reg
. 2024 Aug;
12:100408.
PMID: 39185270
Objectives: This multicenter cohort study describes Aotearoa New Zealand children hospitalized during the country's first wave of sustained SARS-CoV-2 transmission, Omicron variant. Methods: Children younger than 16 years, hospitalized for...
8.
Kandasamy R, Gurung M, Shrestha S, Gautam M, Kelly S, Thorson S, et al.
Vaccine
. 2024 May;
42(19):4066-4071.
PMID: 38789369
Background: Carriage studies are an efficient means for assessing pneumococcal conjugate vaccine effect in settings where pneumococcal disease surveillance programmes are not well established. In this study the effect of...
9.
Carter M, Shrestha S, OReilly P, Gurung P, Gurung M, Thorson S, et al.
Pediatr Infect Dis J
. 2024 May;
43(2):e67-e70.
PMID: 38758207
We evaluated whether the quantification of IgG to pneumococcal capsular polysaccharides is an accurate diagnostic test for pneumococcal infection in children with pneumonia in Nepal. Children with pneumococcal pneumonia did...
10.
Gallagher K, Awori J, Knoll M, Rhodes J, Higdon M, Hammitt L, et al.
PLoS One
. 2024 Mar;
19(3):e0297159.
PMID: 38466696
Introduction: In 2012, the World Health Organization revised treatment guidelines for childhood pneumonia with lower chest wall indrawing (LCWI) but no 'danger signs', to recommend home-based treatment. We analysed data...